97209-05-7 Usage
Uses
Used in Pharmaceutical Industry:
4-CHLORO-3-ETHOXYBENZOIC ACID is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic benefits.
Used in Agrochemical Industry:
In the agrochemical sector, 4-CHLORO-3-ETHOXYBENZOIC ACID is utilized as an intermediate in the production of agrochemicals, playing a role in the creation of compounds that can enhance crop protection and yield.
Used in Dye and Pigment Production:
4-CHLORO-3-ETHOXYBENZOIC ACID is employed as a starting material in the manufacturing process of dyes and pigments, contributing to the coloration and stability of these products in various applications.
Used in Organic Synthesis:
As a building block in organic synthesis, 4-CHLORO-3-ETHOXYBENZOIC ACID is used for the creation of a variety of organic compounds, highlighting its importance in the chemical industry for the development of new materials and substances.
Used in Research and Development:
4-CHLORO-3-ETHOXYBENZOIC ACID is utilized in research for its potential anti-inflammatory and analgesic properties, indicating its use in the discovery and development of new treatments for pain and inflammation.
Check Digit Verification of cas no
The CAS Registry Mumber 97209-05-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,2,0 and 9 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 97209-05:
(7*9)+(6*7)+(5*2)+(4*0)+(3*9)+(2*0)+(1*5)=147
147 % 10 = 7
So 97209-05-7 is a valid CAS Registry Number.
97209-05-7Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK
-
, (2014/05/24)
Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
BENZOIMIDAZOLE, TETRAHYDRO-QUINOXALINE, BENZOTRIAZOLE, DIHYDRO-IMIDAZO[4,5-c] PYRIDINONE AND DIHYDRO-ISOINDOLONE DERIVATIVES
-
Page/Page column 24, (2008/12/08)
This invention relates to compounds of the formula wherein A, R1 to R3 are as defined in the specification and G is benzoimidazole, quinoxaline, benzotriazole, dihydro-imidazo[4,5-c]pyridine and dihydro-isoindolone group as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
